In conclusion, our studies suggest that miRNA-148a is significantly correlated with tumor progression and poor clinical outcome and can inhibit the migration and invasion of lung cancer cells by directly targeting Wnt1. The gene discussed is WNT1; the disease is lung carcinoma.